Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Children's Health Orange County (CHOC), Orange, California Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts